FI49497C - Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes. - Google Patents

Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.

Info

Publication number
FI49497C
FI49497C FI683535A FI353568A FI49497C FI 49497 C FI49497 C FI 49497C FI 683535 A FI683535 A FI 683535A FI 353568 A FI353568 A FI 353568A FI 49497 C FI49497 C FI 49497C
Authority
FI
Finland
Prior art keywords
alkylaminopropanes
phenoxy
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI683535A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI49497B (en
Inventor
Herbert Koeppe
Werner Kummer
Helmut Staehle
Karl Zeile
Albrecht Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of FI49497B publication Critical patent/FI49497B/fi
Publication of FI49497C publication Critical patent/FI49497C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI683535A 1967-12-13 1968-12-11 Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes. FI49497C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1643262A DE1643262C3 (en) 1967-12-13 1967-12-13 i-Phenoxy ^ -hydroxy-S-alklyaminopropane, process for their preparation and medicaments containing these compounds

Publications (2)

Publication Number Publication Date
FI49497B FI49497B (en) 1975-04-01
FI49497C true FI49497C (en) 1975-07-10

Family

ID=5684274

Family Applications (1)

Application Number Title Priority Date Filing Date
FI683535A FI49497C (en) 1967-12-13 1968-12-11 Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.

Country Status (21)

Country Link
US (1) US3872147A (en)
JP (1) JPS5220457B1 (en)
AT (13) AT292673B (en)
BE (1) BE725490A (en)
BG (9) BG17298A3 (en)
BR (1) BR6804840D0 (en)
CA (1) CA954528A (en)
CH (2) CH556816A (en)
DE (1) DE1643262C3 (en)
DK (1) DK131029B (en)
ES (11) ES361189A1 (en)
FI (1) FI49497C (en)
FR (2) FR1596100A (en)
GB (1) GB1260866A (en)
HU (1) HU162734B (en)
IE (1) IE32758B1 (en)
IL (1) IL31266A (en)
NL (3) NL146709B (en)
PH (1) PH9266A (en)
SE (1) SE367396B (en)
YU (12) YU33949B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3998874A (en) * 1971-03-23 1976-12-21 Gist-Brocades N.V. Phenylene di-ethers
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
DE2309887C2 (en) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-aryloxy-2-hydroxy-3-alkynylaminopropane derivatives and their physiologically acceptable acid addition salts, pharmaceutical preparations and manufacturing processes for the compounds
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4094991A (en) * 1975-06-17 1978-06-13 Nippon Shinyaku Co., Ltd. Substituted n-(carboxymethyl)-3-aminopropan-2-ol derivatives
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2839475A1 (en) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik ISOPROPYLAMINE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
JPS56142262A (en) 1980-04-08 1981-11-06 Nippon Shinyaku Co Ltd Piperazine derivative
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
DE3131527A1 (en) * 1981-08-08 1983-02-24 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-PHENYL-2-AMINOCARBONYLINDOL COMPOUNDS AND METHODS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
ATE45724T1 (en) * 1985-12-24 1989-09-15 Merck & Co Inc OCULOSELECTIVE BETA BLOCKERS.
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Also Published As

Publication number Publication date
YU237974A (en) 1977-12-31
ES375445A1 (en) 1972-05-16
DE1643262B2 (en) 1974-11-07
NL146709B (en) 1975-08-15
YU33773B (en) 1978-05-15
NL6817768A (en) 1969-06-17
ES375444A1 (en) 1972-05-01
ES375450A1 (en) 1972-05-01
YU33856B (en) 1978-06-30
YU33851B (en) 1978-06-30
JPS5220457B1 (en) 1977-06-03
ES375448A1 (en) 1972-05-01
YU238074A (en) 1977-12-31
FR8328M (en) 1970-12-07
YU294968A (en) 1978-02-28
YU237874A (en) 1977-12-31
ES375452A1 (en) 1972-05-16
YU33855B (en) 1978-06-30
YU33949B (en) 1978-09-08
AT294799B (en) 1971-12-10
DK131029C (en) 1975-10-06
YU33948B (en) 1978-09-08
ES375451A1 (en) 1972-05-01
BG16331A3 (en) 1972-08-20
AT292676B (en) 1971-09-10
AT292680B (en) 1971-09-10
BE725490A (en) 1969-06-13
YU33853B (en) 1978-06-30
AT292674B (en) 1971-09-10
BG16330A3 (en) 1972-08-20
DK131029B (en) 1975-05-20
BG17298A3 (en) 1973-07-25
BG16332A3 (en) 1972-08-20
AT292670B (en) 1971-09-10
NL7501794A (en) 1975-05-30
PH9266A (en) 1975-07-30
DE1643262A1 (en) 1972-04-20
AT292675B (en) 1971-09-10
ES361189A1 (en) 1970-08-16
YU237574A (en) 1978-02-28
IE32758L (en) 1969-06-13
YU238474A (en) 1978-02-28
SE367396B (en) 1974-05-27
YU237774A (en) 1978-02-28
US3872147A (en) 1975-03-18
IL31266A (en) 1974-09-10
AT292678B (en) 1971-09-10
AT292673B (en) 1971-09-10
DE1643262C3 (en) 1975-06-26
YU237674A (en) 1977-10-31
YU238374A (en) 1977-12-31
BR6804840D0 (en) 1973-03-08
YU33854B (en) 1978-06-30
YU237474A (en) 1977-12-31
ES375447A1 (en) 1972-05-01
BG16329A3 (en) 1972-08-20
CH556816A (en) 1974-12-13
ES375453A1 (en) 1972-05-16
IL31266A0 (en) 1969-02-27
GB1260866A (en) 1972-01-19
AT298459B (en) 1972-05-10
YU33774B (en) 1978-05-15
HU162734B (en) 1973-04-28
FR1596100A (en) 1970-06-15
NL151354B (en) 1976-11-15
AT292679B (en) 1971-09-10
ES375449A1 (en) 1972-05-01
YU33947B (en) 1978-09-08
AT292681B (en) 1971-08-15
BG19135A3 (en) 1975-04-30
FI49497B (en) 1975-04-01
ES375446A1 (en) 1972-05-01
BG16444A3 (en) 1972-11-20
NL7501792A (en) 1975-05-30
YU238274A (en) 1977-12-31
YU33852B (en) 1978-06-30
YU238174A (en) 1977-10-31
AT298463B (en) 1972-05-10
CA954528A (en) 1974-09-10
AT292677B (en) 1971-09-10
BG17297A3 (en) 1973-07-25
BG16445A3 (en) 1972-11-20
CH532015A (en) 1972-12-31
YU33946B (en) 1978-09-08
IE32758B1 (en) 1973-11-28

Similar Documents

Publication Publication Date Title
DK128353B (en) Analogous process for the preparation of therapeutically active bis-chromones.
FI42712C (en) Process for the preparation of therapeutically active biphenylalkane derivatives
FI49957C (en) Process for the preparation of therapeutically active oxime ethers i.
FI49497C (en) Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.
FI48727C (en) Process for the preparation of acetylguanidines.
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
FI49720C (en) Process for the preparation of therapeutically active 2-methyl-3-carboxylic acid amidoquinoxaline di-N-oxides (1,4).
FI52857C (en) Process for the preparation of therapeutically active amidoximes.
FI45551C (en) Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate.
DK117635B (en) Analogous process for the preparation of therapeutically active 3- (piperazinoalkyl) -pyrazoles.
FI49718C (en) Process for the preparation of therapeutically active 2-halomethyl-3-carboxylic acid amidoquinoxaline di-N-oxides- (1,4).
FI51175C (en) Process for the preparation of indanylthiocarbamates for therapeutic use.
FI49032C (en) Process for the preparation of therapeutically active 7-nitro-8-hydroxyquinoline esters.
FI50420C (en) Process for the preparation of therapeutically active 4-pyrimidinyl-1,4-dihydropyridine derivatives
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
FI46066C (en) Analogous process for the preparation of therapeutically active N, N-dimethylamino-ethyl-14beta-hydroxy-5beta-pregn-20-ene-21-carboxylates.
FI48190C (en) Process for the preparation of therapeutically active 10alpha-methoxy-9,10-dihydroergoline derivatives
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI48841C (en) Process for the preparation of pharmacologically active 5-nitro-2-furfurylideneaminooxazolidinones.
FI45553C (en) Method for the preparation of therapeutically useful 16-thio-substituted 9beta, 10a lfa-pregnenes
FI47661C (en) Process for the preparation of therapeutically active benzofuran derivatives.
FI47651C (en) Process for the preparation of nitrous oxide.
FI49722C (en) Process for the preparation of therapeutically active 3-carboxylic acid amidoquinoxaline-di-N-oxides- (1,4).
DK122763B (en) Analogous process for the preparation of therapeutically active 1,2α-methylene-4-pregnene-3,20-dione derivatives.